SNX27
Basic information
Region (hg38): 1:151612006-151699091
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- Severe myoclonic epilepsy in infancy (13 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SNX27 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 117 | 123 | ||||
missense | 155 | 164 | ||||
nonsense | 8 | |||||
start loss | 1 | |||||
frameshift | 9 | |||||
inframe indel | 5 | |||||
splice donor/acceptor (+/-2bp) | 7 | |||||
splice region | 6 | 22 | 5 | 33 | ||
non coding | 49 | 54 | ||||
Total | 13 | 3 | 168 | 177 | 10 |
Highest pathogenic variant AF is 0.00000658
Variants in SNX27
This is a list of pathogenic ClinVar variants found in the SNX27 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-151612201-G-GAAGGGACATAGTAATTTCCGTTGTTTCATGTTCTAATCTGTATATGGAAGTTTCATTGACAAGCTCATAAAATGGCAGTTCCACACAACTTTGGGAAGCAATAATTTACATTATTAAAATTATCCTGAAA | Severe myoclonic epilepsy in infancy | Uncertain significance (Jun 29, 2021) | ||
1-151612207-G-T | Severe myoclonic epilepsy in infancy | Likely benign (Jul 26, 2022) | ||
1-151612215-A-C | Severe myoclonic epilepsy in infancy | Uncertain significance (Sep 24, 2021) | ||
1-151612216-C-G | Severe myoclonic epilepsy in infancy • Inborn genetic diseases | Uncertain significance (May 20, 2024) | ||
1-151612216-C-T | Severe myoclonic epilepsy in infancy | Likely benign (Mar 24, 2018) | ||
1-151612217-G-C | Inborn genetic diseases • Severe myoclonic epilepsy in infancy | Uncertain significance (Sep 15, 2022) | ||
1-151612218-G-A | Severe myoclonic epilepsy in infancy | Uncertain significance (Jun 02, 2022) | ||
1-151612218-G-T | Severe myoclonic epilepsy in infancy • Inborn genetic diseases | Uncertain significance (Aug 30, 2023) | ||
1-151612219-G-A | Severe myoclonic epilepsy in infancy | Benign (Jan 25, 2024) | ||
1-151612220-G-A | Severe myoclonic epilepsy in infancy | Uncertain significance (Sep 08, 2020) | ||
1-151612221-A-G | Inborn genetic diseases | Uncertain significance (Apr 01, 2024) | ||
1-151612228-T-G | Severe myoclonic epilepsy in infancy | Uncertain significance (Jul 02, 2022) | ||
1-151612232-C-T | Inborn genetic diseases | Uncertain significance (May 31, 2023) | ||
1-151612234-C-T | Severe myoclonic epilepsy in infancy | Likely benign (Nov 08, 2021) | ||
1-151612241-C-A | Severe myoclonic epilepsy in infancy | Uncertain significance (Aug 28, 2021) | ||
1-151612241-C-T | Severe myoclonic epilepsy in infancy • Inborn genetic diseases | Uncertain significance (Mar 31, 2024) | ||
1-151612242-C-T | Severe myoclonic epilepsy in infancy • Inborn genetic diseases | Uncertain significance (May 18, 2022) | ||
1-151612246-C-G | Inborn genetic diseases | Uncertain significance (Jan 26, 2022) | ||
1-151612250-A-C | Severe myoclonic epilepsy in infancy | Uncertain significance (Aug 24, 2021) | ||
1-151612254-G-C | Severe myoclonic epilepsy in infancy | Uncertain significance (Jun 13, 2022) | ||
1-151612257-G-A | Severe myoclonic epilepsy in infancy • Inborn genetic diseases | Uncertain significance (Aug 31, 2022) | ||
1-151612258-T-TGGC | Severe myoclonic epilepsy in infancy | Benign (Jan 29, 2024) | ||
1-151612258-T-TGGCGGC | Severe myoclonic epilepsy in infancy | Uncertain significance (Jul 25, 2022) | ||
1-151612260-G-T | Inborn genetic diseases | Uncertain significance (Jan 03, 2024) | ||
1-151612270-C-T | Severe myoclonic epilepsy in infancy | Likely benign (Dec 31, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SNX27 | protein_coding | protein_coding | ENST00000368843 | 12 | 87027 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.000229 | 125731 | 0 | 17 | 125748 | 0.0000676 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.17 | 179 | 282 | 0.636 | 0.0000152 | 3433 |
Missense in Polyphen | 67 | 114.26 | 0.58636 | 1337 | ||
Synonymous | 1.58 | 92 | 113 | 0.811 | 0.00000666 | 996 |
Loss of Function | 4.98 | 2 | 32.8 | 0.0610 | 0.00000205 | 345 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000148 | 0.000148 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000440 | 0.0000439 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000229 | 0.000229 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in the retrograde transport from endosome to plasma membrane, a trafficking pathway that promotes the recycling of internalized transmembrane proteins. Following internalization, endocytosed transmembrane proteins are delivered to early endosomes and recycled to the plasma membrane instead of being degraded in lysosomes. SNX27 specifically binds and directs sorting of a subset of transmembrane proteins containing a PDZ- binding motif at the C-terminus: following interaction with target transmembrane proteins, associates with the retromer complex, preventing entry into the lysosomal pathway, and promotes retromer-tubule based plasma membrane recycling. SNX27 also binds with the WASH complex. Interacts with membranes containing phosphatidylinositol-3-phosphate (PtdIns(3P)). May participate in establishment of natural killer cell polarity. Recruits CYTIP to early endosomes. {ECO:0000269|PubMed:17351151, ECO:0000269|PubMed:20733053, ECO:0000269|PubMed:21300787, ECO:0000269|PubMed:21303929, ECO:0000269|PubMed:21602791, ECO:0000269|PubMed:21926430, ECO:0000269|PubMed:22411990, ECO:0000269|PubMed:23563491}.;
Recessive Scores
- pRec
- 0.0851
Intolerance Scores
- loftool
- 0.118
- rvis_EVS
- 0.06
- rvis_percentile_EVS
- 58.53
Haploinsufficiency Scores
- pHI
- 0.155
- hipred
- Y
- hipred_score
- 0.653
- ghis
- 0.484
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.890
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Snx27
- Phenotype
- growth/size/body region phenotype; cellular phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); liver/biliary system phenotype; immune system phenotype; digestive/alimentary phenotype;
Gene ontology
- Biological process
- establishment of natural killer cell polarity;intracellular protein transport;signal transduction;endosome to lysosome transport;endosomal transport;retrograde transport, endosome to plasma membrane
- Cellular component
- immunological synapse;nucleoplasm;endosome;early endosome;cytosol;retromer complex;early endosome membrane;WASH complex
- Molecular function
- protein binding;phosphatidylinositol-3-phosphate binding;phosphatidylinositol binding